Chemex Pharmaceuticals Inc. (NASDAQ:CHMX) of Fort Lee, N.J.,announced that it has filed an investigational new drug (IND)application with FDA for CHX3311 (cytarabine) for treatingvenereal warts. Chemex licensed the drug from the Upjohn Co.,which has relied on its anti-viral and anti-proliferativeproperties for treating leukemia.

(c) 1997 American Health Consultants. All rights reserved.

No Comments